FDA Warns iRhythm Technologies Over Zio Cardiac Telemetry Device Violations
San Francisco, California – The U.S. Food and Drug Administration (FDA) recently sent a warning letter to iRhythm Technologies regarding issues related to their Zio AT mobile cardiac telemetry device. The letter, dated May 25, was made public on the agency’s website on June 6, shedding light on various concerns the FDA had with the … Read more